Log in to save to my catalogue

TMED inhibition suppresses cell surface PD-1 expression and overcomes T cell dysfunction

TMED inhibition suppresses cell surface PD-1 expression and overcomes T cell dysfunction

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_b3b1db25d0594fcdad82ad2a293ad050

TMED inhibition suppresses cell surface PD-1 expression and overcomes T cell dysfunction

About this item

Full title

TMED inhibition suppresses cell surface PD-1 expression and overcomes T cell dysfunction

Publisher

England: BMJ Publishing Group Ltd

Journal title

Journal for immunotherapy of cancer, 2024-11, Vol.12 (11), p.e010145

Language

English

Formats

Publication information

Publisher

England: BMJ Publishing Group Ltd

More information

Scope and Contents

Contents

BackgroundBlockade of the programmed cell death protein 1 (PD-1) immune checkpoint (ICB) is revolutionizing cancer therapy, but little is known about the mechanisms governing its expression on CD8 T cells. Because PD-1 is induced during activation of T cells, we set out to uncover regulators whose inhibition suppresses PD-1 abundance without advers...

Alternative Titles

Full title

TMED inhibition suppresses cell surface PD-1 expression and overcomes T cell dysfunction

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_b3b1db25d0594fcdad82ad2a293ad050

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_b3b1db25d0594fcdad82ad2a293ad050

Other Identifiers

ISSN

2051-1426

E-ISSN

2051-1426

DOI

10.1136/jitc-2024-010145

How to access this item